Neuropsychiatric Disorders in Cushing's Syndrome

被引:109
作者
Pereira, Alberto M. [1 ]
Tiemensma, Jitske [1 ]
Romijn, Johannes A. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2333 ZA Leiden, Netherlands
关键词
Cushing's syndrome; Treatment; Depression; Mania; Psychopathology; QUALITY-OF-LIFE; PITUITARY-ADENOMAS; DISEASE; PERSONALITY; CORTISOL; PSYCHOPATHOLOGY; MANIFESTATIONS; DEPRESSION; CURE;
D O I
10.1159/000314317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids are crucial in the initiation and consolidation of the stress response. Patients with active Cushing's syndrome (CS) are exposed to excessive endogenous glucocorticoid levels. In these patients, psychopathology is often being observed. The most common co-morbid disorder is major depression, but to a lesser extent mania and anxiety disorders have also been reported. A severe clinical presentation of CS often also includes depression. Reduction of glucocorticoid synthesis or action, either with metyrapone, ketoconazole, or mifepristone, rather than treatment with antidepressant drugs, is generally successful in relieving depressive symptoms, as well as other disabling symptoms. Following successful surgical treatment of hypercortisolism, both physical and psychiatric signs and symptoms improve substantially. However, it appears that patients do not completely return to their premorbid level of functioning and persistent impairment of quality of life and cognitive function has been reported despite long-term cure. At present, it is not clear whether, and to which extent, psychopathology still affects general well-being after long-term cure of CS. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:65 / 70
页数:6
相关论文
共 50 条
[41]   Functional brain alterations in Cushing's syndrome [J].
Papakokkinou, Eleni ;
Ragnarsson, Oskar .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[42]   Metabolic Syndrome in Cushing's Syndrome [J].
Chanson, Philippe ;
Salenave, Sylvie .
NEUROENDOCRINOLOGY, 2010, 92 :96-101
[43]   Mortality in Patients with Endogenous Cushing's Syndrome [J].
Javanmard, Pedram ;
Duan, Daisy ;
Geer, Eliza B. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (02) :313-+
[44]   Morbidity of Cushing's Syndrome and Impact of Treatment [J].
Webb, Susan M. ;
Valassi, Elena .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (02) :299-+
[45]   Animal models and human neuropsychiatric disorders [J].
Fisch, Gene S. .
BEHAVIOR GENETICS, 2007, 37 (01) :1-10
[46]   Epidemiology of Cushing's Syndrome [J].
Steffensen, Charlotte ;
Bak, Ann Mosegaard ;
Rubeck, Kristine Zoylner ;
Jorgensen, Jens Otto Lunde .
NEUROENDOCRINOLOGY, 2010, 92 :1-5
[47]   Androgens in Cushing's Syndrome [J].
Arnaldi, Giorgio ;
Martino, Marianna .
HYPERANDROGENISM IN WOMEN: BEYOND POLYCYSTIC OVARY SYNDROME, 2019, 53 :77-91
[48]   CYCLIC CUSHING'S SYNDROME [J].
Krysiak, R. ;
Kedzia, A. ;
Okopien, B. .
ACTA CLINICA BELGICA, 2012, 67 (01) :30-33
[49]   Subclinical Cushing's syndrome [J].
Terzolo M. ;
Reimondo G. ;
Bovio S. ;
Angeli A. .
Pituitary, 2004, 7 (4) :217-223
[50]   Genetics of Cushing's Syndrome [J].
Yaneva, Maria ;
Vandeva, Silvia ;
Zacharieva, Sabina ;
Daly, Adrian F. ;
Beckers, Albert .
NEUROENDOCRINOLOGY, 2010, 92 :6-10